Startups in social impact or wellness often receive positive but misleading feedback from VCs. Investors are hesitant to reject these missions outright, so they offer praise while privately declining due to perceived weak business models and a lack of "cutthroat" founders. This creates a "Save the Whales trap" for idealistic entrepreneurs.

Mission-driven founders often fear being perceived as money-hungry. Separate your personal "why" from the business's needs. The business entity's purpose is to generate profit to survive and grow. This growth is what enables you to fulfill your mission and help more people at scale.

A common pitfall for founders transitioning from a PhD is creating pitch decks that are essentially scientific presentations. Investors are less interested in how the technology works and more interested in the magnitude of the problem it solves and the market's demand for that solution. The 'what' and 'why' trump the 'how'.

Operating as a non-profit removes the fiduciary duty to investors, granting freedom to prioritize the mission over profits. However, this lack of a potential return on investment (ROI) is a major hurdle, often causing potential donors to reject the pitch, even if they claim they would have invested in a for-profit version.

When evaluating founders coming from academia, VCs should distinguish between those fixated on a niche problem and those driven by real-world impact. The latter are more likely to find a problem that generates revenue and successfully transition from a science project to a viable company.

To secure funding, founders with a social mission must demonstrate how responsible, purpose-driven practices lead to better financial results, growth, and competitiveness, making a clear business case to investors.

If you struggle to raise capital, the problem isn't your pitch; it's the underlying business model. An offer with a high and fast return on invested capital (ROIC) naturally attracts investment. Focus on fixing the core economics before trying to improve your sales pitch to investors.

For investor Nick Pachuda, a key founder test is whether they can describe "the amazing thing" they are working on in terms of clinical or economic impact. Founders who get bogged down in the technical mechanisms often fail to communicate a compelling vision.

While passion for helping patients is a powerful motivator, founders must learn to frame their pitch around value creation for investors. This means explicitly connecting the science and clinical benefit to the commercial market, reimbursement strategy, and ultimate financial return for their limited partners.